Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes

West, Sophie D.; Nicoll, Debby J.; Wallace, Bra M.; Matthews, David R.; Stradling, John R.
November 2007
Thorax;Nov2007, Vol. 62 Issue 11, p969
Academic Journal
Background: The effects of continuous positive airway pressure (CPAP) for obstructive sleep apnoea (OSA) on insulin resistance are not clear. Trials have found conflicting results and no appropriate control groups have been used. Methods: Forty-two men with known type 2 diabetes and newly diagnosed OSA (>10 dips/h in oxygen saturation of >4%) were randomised to receive therapeutic (n = 20) or placebo CPAP (n = 22) for 3 months. Baseline tests were performed and repeated after 3 months. The study was double blind. Results: Results are expressed as mean (SD). CPAP improved the Epworth sleepiness score significantly more in the therapeutic group than in the placebo group (-6.6 (4.5) vs -2.6 (4.9), p=0.01 ). The maintenance of wakefulness test improved significantly in the therapeutic group but not in the placebo group (+10.6 (13.9) vs -4.7 (11.8) min, p=0.001). Glycaemic control and insulin resistance did not significantly change in either the therapeutic or placebo groups: HbAlc (-0.02 (1.5) vs +0.1 (0.7), p=0.7, 95% CI -0.6% to +0.9%), euglycaemic clamp (M/I: +1.7 (14.1) vs -5.7 (14.8), p =0.2, 95% CI -1.8 to +0.3 l/kg/min1000), HOMA-%S (- 1.5 (2.3) vs - 1.1 (1.8), p= 0.2, 95% CI -0.3% to +0.08%) and adiponectin (- 1.1 (1.2) vs - 1.1 (1.3), p = 0.2, 95% CI -0.7 to +0.6 μg/ml). Body mass index, bioimpedance and anthropometric measurements were unchanged. Hours of CPAP use per night were 3.6 (2.8) in the treatment group and 3.3 (3.0) in the placebo group (p = 0.8). There was no correlation between CPAP use and the measures of glycaemic control or insulin resistance. Conclusion: Therapeutic CPAP does not significantly improve measures of glycaemic control or insulin resistance in men with type 2 diabetes and OSA.


Related Articles

  • High Baseline Insulin Levels Associated With 6-Year Incident Observed Sleep Apnea. Balkau, Beverley; Vol, Sylviane; Loko, Sandrine; Andriamboavonjy, Tiana; Lantieri, Olivier; Gusto, Gaelle; Meslier, Nicole; Racineux, Jean-Louis; Tichet, Jean // Diabetes Care;May2010, Vol. 33 Issue 5, p1044 

    OBJECTIVE -- Obstructive sleep apnea is common in patients with type 2 diabetes, and its association with insulin and insulin resistance has been examined in cross-sectional studies. We evaluate risk factors for incident observed sleep apnea in a general population not selected for sleep...

  • Glucose and arterial blood pressure variability in obstructive sleep apnea syndrome. KALLIANOS, A.; TRAKADA, G.; PAPAIOANNOU, T.; NIKOLOPOULOSS, I.; MITRAKOU, A.; MANIOS, E.; KOSTOPOULOS, K.; KOSTOPOULOS, C.; ZAKOPOULOS, N. // European Review for Medical & Pharmacological Sciences;Jul2013, Vol. 17 Issue 14, p1932 

    INTRODUCTION: Current evidence supports an association between Obstructive Sleep Apnea Syndrome (OSAS), insulin resistance, type 2 diabetes mellitus (DM) and cardiovascular disorders. The relationship is complex and still remains poorly understood. AIM: The aim of this study was to examine the...

  • Subjective Sleep Complaints Are Associated With Insulin Resistance in Individuals Without Diabetes. PYYKKÖNEN, ANTTI.-JUSSI; ISOMAA, BO; PESONEN, ANU.-KATRIINA; ERIKSSON, JOHAN G.; GROOP, LEIF; TUOMI, TIINAMAIJA; RÄIKKÖNEN, KATRI // Diabetes Care;Nov2012, Vol. 35 Issue 11, p2271 

    OBJECTIVE--Sleep disorders and subjective sleep complaints have been associated with increased risk of type 2 diabetes. The evidence with respect to insulin resistance (IR) and insulin secretion in individuals without type 2 diabetes has been scarce and elusive. We examined if subjective sleep...

  • Sleep Apnea in Type 2 Diabetes. Doumit, Jimmy; Prasad, Bharati // Diabetes Spectrum;Winter2016, Vol. 29 Issue 1, p14 

    The article discusses the effects of obstructive sleep apnea (OSA) and its treatment on glucose metabolism in adults with prediabetes or type 2 diabetes. Topics covered include the biological pathways through which OSA leads to abnormal glucose homeostasis, the mechanisms of insulin resistance...

  • Obstructive sleep apnoea and type 2 diabetes: A wake-up call. Barker, Sarah J. // Journal of Diabetes Nursing;2011, Vol. 15 Issue 10, p372 

    The link between type 2 diabetes and obstructive sleep apnoea (OSA) is now well-established. Studies suggest that nearly half of men and one fifth of women with type 2 diabetes have moderate OSA. This article looks at the links between OSA, the metabolic syndrome and type 2 diabetes, and...

  • Increased prevalence of obesity in narcoleptic patients and relatives. Dahmen, Norbert; Bierbrauer, Jürgen; Kasten, Meike // European Archives of Psychiatry & Clinical Neuroscience;2001, Vol. 251 Issue 2, p85 

    Abstract Increased Body Mass Indices (BMIs), increased prevalences of non insulin-dependent diabetes and sleep apnoe syndrome have been reported to be associated with narcolepsy. Our objective was to explore and possibly confirm the association of narcolepsy and increased BMI. In addition, we...

  • Clinical Briefs. Kuritzky, Louis // Internal Medicine Alert;9/1/2010, Vol. 32 Issue 18, p144 

    The article offers news briefs related to medical topics including the effectiveness of low-dose combination therapy to prevent type 2 diabetes, the adverse outcomes of obstructive sleep apnea's (OSA) diagnosis and treatment procedures, and the mortality risks associated to bariatric surgery.

  • Effects of sleep apnea severity on glycemic control in patients with type 2 diabetes prior to continuous positive airway pressure treatment.  // Current Medical Literature: Diabetes;2011, Vol. 28 Issue 4, p153 

    The article presents a cross-sectional study on British patients attending a diabetes obesity clinic for obstructive sleep apnea to see whether sleep apnea treatment through continuous positive airway pressure helps improve glycemic control in patients with type 2 diabetes.

  • Diabetes, obstructive sleep apnoea syndrome and ED - what do you ask your patients? Cummings, Mike // Diabetes Digest;2012, Vol. 11 Issue 2, p94 

    The article discusses the importance of investigating type 2 diabetes patients for obstructive sleep apnoea syndrome (OSAS) and erectile dysfunction (ED). Studies support that ED is interrelated with occurrence of OSAS from the aspects of incidence and treatment. It also highlights the necessity...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics